Johnson & Johnson (JNJ) stock analysis

JNJ · Johnson & Johnson

Latest recorded price: USD 278.83

Model-estimated fair value: USD 129.15. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Drug Manufacturers - General

At $278.83, JNJ trades 115.9% above the model's base-case value of $129.15. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $101.63 in the conservative case and $159.04 in the optimistic case, with a valuation confidence score of 45/100. About 78% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth -0.3%, free cash flow margin 20.9%, ROIC 23.6%. The model flags 1 risk signal for this company.

Similar companies in Healthcare